DLC1: a significant GAP in the cancer genome
Abstract
Rho GTPases are believed to make important contributions to the development and progression of human cancer, but direct evidence in the form of somatic mutations analogous to those affecting Ras has been lacking. A recent study in Genes & Development by Xue and colleagues (1439–1444) now provides in vivo evidence that DLC1, a negative regulator of Rho, is a tumor suppressor gene deleted almost as frequently as p53 in common cancers such as breast, colon, and lung.
Keywords
Footnotes
-
↵1 Corresponding author.
↵1 E-MAIL halla{at}mskcc.org; FAX (212) 639-1111.
-
Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.1691408.
- Copyright © 2008, Cold Spring Harbor Laboratory Press
